Are Statins Worth The Risk? | The Real Numbers on Side

For most people with cardiovascular disease or at high risk, the heart attack and stroke prevention benefits of statins likely outweigh the small.

Statins have a PR problem. Walk into any waiting room and you will hear someone say they heard statins “cause diabetes” or “destroy your muscles.” The internet is full of horror stories about debilitating pain, fuzzy thinking, and permanent damage. Meanwhile, cardiologists keep prescribing them — more than 200 million prescriptions per year worldwide — because the data on heart attack and stroke prevention is hard to ignore.

So who is right? The short answer is that both camps have pieces of the truth. Statins do carry real risks, including a small increase in blood sugar and muscle aches for some people. But for most patients who already have heart disease or sit at high risk for it, the protection against a first or second heart attack vastly outweighs those risks. The question is not black and white — it depends on your personal health picture.

Understanding the Risk-Benefit Equation for Statins

Statins work by blocking an enzyme your liver uses to make cholesterol. Lower LDL cholesterol means less plaque buildup in your arteries, fewer blockages, and — for the population that needs them — fewer heart attacks and strokes. Mayo Clinic describes this as a well-understood mechanism where the liver produces less cholesterol overall.

The benefit numbers are substantial at the population level. One analysis found that people taking statins had about 29% fewer heart attacks and 14% fewer strokes compared with those who did not take them. The relative reduction in deaths was about 9%. Those are not small effects for a daily pill.

The side effect numbers are smaller. Most large trials report that serious muscle pain occurs in roughly 1 to 5 percent of users, and the blood sugar effect translates to a small absolute increase in diabetes diagnosis — roughly one extra case per 200 to 500 patient-years of treatment, depending on the study. That ratio matters when you weigh the two sides of the scale.

Why the “Worth It” Question Gets Complicated

The confusion comes from how risks and benefits feel different depending on who you are. Someone who has already survived a heart attack feels the benefit personally. Someone with normal cholesterol and no family history may never feel the benefit — they only feel the pill.

Several factors influence whether the trade-off makes sense for you:

• Your baseline cardiovascular risk: If you have had a heart attack, stroke, or have known coronary artery disease, the benefit is large — statins can cut your risk of a second event by 25 to 35 percent. If you have no known disease and only mildly elevated cholesterol, the benefit is smaller and the decision requires more nuance.
• Your blood sugar profile: People with prediabetes or metabolic syndrome have a slightly higher chance of seeing a blood sugar rise on statins. The CDC notes that statins can interfere with how your body uses insulin — a small effect, but one worth discussing if you are already close to the diabetes threshold.
• Your statin type and dose: Lipophilic statins like atorvastatin and simvastatin are somewhat more likely to cause muscle aches than hydrophilic alternatives like pravastatin or rosuvastatin. Cleveland Clinic explains that lipophilic statins passively diffuse into muscle tissue, which may explain the difference.
• Your tolerance for uncertainty: If you experience any side effect, a lower dose or a switch to a different statin often resolves it. Johns Hopkins researchers emphasize that most people tolerate statins well over the long term — decades of monitoring data support that.

The key insight is that “worth it” is not a global answer. It depends on whether you are treating existing disease or chasing a number on a lab slip. Your doctor has access to risk calculators that can show you your personal 10-year heart attack risk — that number is the starting point for an honest conversation.

Blood Sugar and Diabetes Risk — What the Numbers Actually Show

The blood sugar question is the one that worries most people. The science is clear that statins cause a small average increase in HbA1c — roughly 0.1 to 0.3 percentage points in large trials. That is enough to push someone with prediabetes over the diagnostic line for type 2 diabetes in some cases, but it is a modest shift for most people.

Clinicians use a tool called the Cogr statin diabetes risk assessment to weigh this specific trade-off. The assessment compares your personal diabetes risk factors against your cardiovascular risk factors and helps determine whether the blood sugar change is likely to matter in your case. For most patients, the cardiovascular protection still comes out ahead.

One way to think about it: the small diabetes risk from statins takes years to develop into complications. The protection against heart attack is immediate — the next plaque rupture that would have sent you to the ER does not happen. Cardiologists generally consider that a favorable exchange, especially for people with existing heart disease or diabetes.

Muscle Pain and Other Side Effects — How Common Are They Really?

Muscle aches are the most frequently reported statin side effect, and they are also the most debated. In placebo-controlled trials, the rate of muscle pain in the statin group is only slightly higher than in the placebo group — roughly 5 to 10 percent versus 4 to 8 percent. That gap is small, and it suggests that some of the muscle pain attributed to statins may be due to other causes or the “nocebo” effect (expecting side effects makes them more likely to be felt).

Other side effects reported include digestive upset, headache, and — in very rare cases — liver enzyme elevation. The liver changes are almost always mild and reversible; routine monitoring of liver enzymes, once standard, is now considered unnecessary for most patients unless they have pre-existing liver conditions. The table below summarizes the key side effects and their approximate frequency.

If you experience muscle pain that you suspect is from your statin, do not stop the pill cold turkey. Talk to your doctor about a lower dose, a different statin, or a different dosing schedule — some people find taking the medication every other day reduces aches while still controlling cholesterol. A statin intolerance clinic, such as the one at Mayo Clinic, exists specifically to help patients who struggle with side effects find a regimen that works.

Who Benefits Most from Statin Therapy

Statins are not a one-size-fits-all medication. The people who get the clearest benefit are those with established cardiovascular disease — prior heart attack, stroke, stent, or bypass surgery. In this group, daily statin use can lower the risk of a second event by 25 to 35 percent, which is a dramatic reduction for a single pill.

For people without established disease but with elevated risk factors (high LDL, diabetes, smoking, family history of early heart disease), the benefit is smaller but still meaningful in many cases. The CDC has a helpful resource on statins and blood sugar increase that explains how this group — people with diabetes or prediabetes — can still benefit from cholesterol-lowering therapy if their cardiovascular risk is high enough.

The next table shows which patient groups typically see the strongest risk-reduction benefit.

The trend in cardiology is toward more personalized decision-making. Risk calculators like the ACC/AHA Pooled Cohort Equations estimate your 10-year risk of heart attack or stroke. If your risk is above 7.5 percent, guidelines generally recommend discussing a statin. If it is below 5 percent, the benefit may be too small to justify the pill, and lifestyle changes become the primary strategy.

The Bottom Line

Statins are worth the risk for most people who have cardiovascular disease or a 10-year risk above 7.5 percent. The blood sugar and muscle side effects are real but modest for most users, and options exist to manage them if they appear. The larger risk — the one you cannot feel — is the heart attack or stroke that a statin would have prevented.

Your cardiologist or primary care doctor can run your personal risk numbers and match them against the specific statin options available, including the small chance of a blood sugar increase that the CDC tracks in its diabetes-and-statins monitoring data. That conversation — with your lab values and your family history in hand — is where the real answer lives.